- Home
- NIM vs BDTX Comparison
NIM vs BDTX Comparison
Compare NIM & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIM
- BDTX
- Stock Information
- Founded
- NIM 1992
- BDTX 2014
- Country
- NIM United States
- BDTX United States
- Employees
- NIM N/A
- BDTX N/A
- Industry
- NIM Trusts Except Educational Religious and Charitable
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NIM Finance
- BDTX Health Care
- Exchange
- NIM Nasdaq
- BDTX Nasdaq
- Market Cap
- NIM 112.0M
- BDTX 126.8M
- IPO Year
- NIM N/A
- BDTX 2020
- Fundamental
- Price
- NIM $9.04
- BDTX $2.50
- Analyst Decision
- NIM
- BDTX Strong Buy
- Analyst Count
- NIM 0
- BDTX 4
- Target Price
- NIM N/A
- BDTX $15.50
- AVG Volume (30 Days)
- NIM 35.4K
- BDTX 1.4M
- Earning Date
- NIM 01-01-0001
- BDTX 03-11-2025
- Dividend Yield
- NIM 3.46%
- BDTX N/A
- EPS Growth
- NIM N/A
- BDTX N/A
- EPS
- NIM N/A
- BDTX N/A
- Revenue
- NIM N/A
- BDTX N/A
- Revenue This Year
- NIM N/A
- BDTX N/A
- Revenue Next Year
- NIM N/A
- BDTX N/A
- P/E Ratio
- NIM N/A
- BDTX N/A
- Revenue Growth
- NIM N/A
- BDTX N/A
- 52 Week Low
- NIM $8.28
- BDTX $1.91
- 52 Week High
- NIM $9.74
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- NIM 66.26
- BDTX 52.62
- Support Level
- NIM $8.88
- BDTX $2.30
- Resistance Level
- NIM $9.03
- BDTX $2.82
- Average True Range (ATR)
- NIM 0.10
- BDTX 0.23
- MACD
- NIM 0.02
- BDTX 0.04
- Stochastic Oscillator
- NIM 74.29
- BDTX 53.69
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital by investing in an investment-grade quality portfolio of municipal obligations with intermediate characteristics.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.